Professional diabetes and healthcare quality organizations have identified patient-centered care as a means to improve practice quality and healthcare outcomes for patients with type 2 diabetes mellitus (T2DM). Consistent with this perspective, recent practice recommendations for the management of hyperglycemia in T2DM emphasize individualized care. In addition to considering the efficacy and complementary actions of the currently available antihyperglycemic agents, healthcare professionals (HCPs) are encouraged to consider patient-related factors such as patient preferences, unique clinical characteristics, nonglycemic effects (eg, weight, cardiovascular), and susceptibilities to adverse effects when making individual treatment selections. Additionally, diabetes HCPs should be aware of information on new or emerging agents so that as these therapies become available, they can be effectively incorporated into individualized treatment regimens.
This program is designed to facilitate competent patient-centered diabetes care by: